EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...

Released by the Madhya Pradesh Board of Secondary Education (MPBSE), the updated syllabus strictly follows NCERT guidelines, ...

Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) AFARAK GROUP SE: NOTIFICATION PURSUANT TO CHAPTER 9, ...